HIV Infection
Resource Center
Featured
06/29/2022
The USPSTF released recommendations about HIV screening and PrEP use. What impact do you think the recommendations will have?
06/29/2022
06/25/2022
Consultant360 spoke with Keith Horvath, PhD, about his study, which indicated that technology-assisted HIV testing interventions could serve as a key strategy in reaching national and global targets for HIV...
06/25/2022
05/20/2022
PrEP has become more mainstream in the media, and the USPSTF recently recommended PrEP for all at-risk populations. Richard Chaisson, MD, shines light on these at-risk populations.
05/20/2022
Interactive Features
06/29/2022
The USPSTF released recommendations about HIV screening and PrEP use. What impact do you think the recommendations will have?
06/29/2022
02/16/2022
As a primary care practitioner, do you prescribe pre-exposure prophylaxis (PrEP) to eligible patients who are at risk of acquiring HIV infection?
02/16/2022
09/24/2021
Which of the following are characteristics of primary HIV infection in users of pre-exposure prophylaxis?
09/24/2021
08/06/2021
In this "Test Your Knowledge" quiz series, Maile Young Karris, MD, asks you to advise a patient who is concerned about her weight gain after switching to her current antiretroviral therapy.
08/06/2021
06/22/2021
According to the US Department of Health and Human Services, maintaining what level of HIV RNA with antiretroviral therapy prevents the transmission of HIV to sexual partners?
06/22/2021
Clinical Insights
06/25/2022
Consultant360 spoke with Keith Horvath, PhD, about his study, which indicated that technology-assisted HIV testing interventions could serve as a key strategy in reaching national and global targets for HIV...
06/25/2022
05/20/2022
PrEP has become more mainstream in the media, and the USPSTF recently recommended PrEP for all at-risk populations. Richard Chaisson, MD, shines light on these at-risk populations.
05/20/2022
04/11/2022
In this podcast, Dr Landovitz discusses the findings from his recent trial, HPTN 083, which indicates that long-acting cabotegravir injected once every 8 weeks is superior to daily oral TDF/FTC in the...
04/11/2022
10/14/2021
In this podcast, Niha Idrees, PharmD, and Melissa Badowski, PharmD, MPH, BCIDP, speak about their team's research evaluating the incidence of hypertension, diabetes, and hyperlipidemia in patients on...
10/14/2021
09/21/2021
In this podcast, Sonia Singh, PhD, talks about HIV testing before HIV diagnosis in the Black population in the United States from 2013 to 2018, including ways to help make routine HIV testing more...
09/21/2021
